Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top
Puma therapeutics top

Puma therapeutics top

Puma therapeutics top, Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib an Investigational Aurora Kinase A Inhibitor Business Wire top

$37.00

SKU: 7353819

Colour
  • Puma Biotechnology Inc. LinkedIn
  • Puma Biotechnology Inc
  • Puma therapeutics sales
  • Puma therapeutics top
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus